Researchers identify PPP2R1A gene mutations as a new marker linked to better immunotherapy response and survival in ovarian and other cancers.

Florida Atlantic University researchers have secured two key grants to investigate targeting a gene for the first time as a new approach to treat...

A concerning rise in colorectal and other gastrointestinal cancers is observed among younger individuals, contrasting with declining rates in older...

The RNA-binding protein IGF2BP1 has emerged as a key regulator of cancer hallmarks, influencing tumour proliferation, metastasis, immune evasion, and...

The RNA-binding protein IGF2BP1 has emerged as a key regulator of cancer hallmarks, influencing tumour proliferation, metastasis, immune evasion, and...

When cancer spreads from a primary tumour to new sites throughout the body, it undergoes changes that increase its genetic complexity. A new study...

A team of researchers from the San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET, Milan), led by Nadia Coltella and Luigi Naldini, has...

Researchers have discovered that bpatients with ovarian clear cell carcinoma (OCCC) who carry certain mutations in the PPP2R1A gene /b respond more...

Advanced treatments, known as immunotherapies that activate T cells—our body’s immune cells—to eliminate cancer cells, have shown limited...

Advanced treatments, known as immunotherapies that activate T cells—our body’s immune cells—to eliminate cancer cells, have shown limited...